Prevalence of Barrett’s Esophagitis in Erosive Esophagitis


About this study

The purpose of this study is to learn more about the prevalence of gastroesophageal reflux among patients with esophagitis using long term proton-pump-inhibitor use.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Inclusion Criteria:

  1. Adults ages 18-90
  2. LA grade B, C, or D esophagitis on EGD performed at Mayo Clinic
  3. Repeat EGD preformed within 6 months at the Mayo Clinic

Exclusion Criteria:

  1. Technically limited EGD
  2. Evidence of achalasia or aperisalsis on high resolution esophageal manometry
  3. Previous history of upper gastrointestinal surgery (e.g. fundoplication, bariatric surgery

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Karthik Ravi, M.D.

Closed for enrollment

Contact information:

Crystal Lavey


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer